Info Edge Appoints Himanshu Agarwal as CFO and Whole-time Director
Info Edge appointed Himanshu Agarwal as Whole-time Director and CFO, effective September 17, 2026, for a five-year term. Mr. Agarwal has over 30 years of finance leadership experience. The company also reconstituted its Board Committees effective June 27, 2026.
The appointment of a key managerial personnel like the CFO and the re-constitution of board committees can significantly impact the company's strategic direction and operational efficiency. The term of appointment and the smooth transition plans suggest a medium-term impact.
The appointment of a seasoned professional as CFO and Whole-time Director, along with the re-constitution of board committees for smooth transitions, are positive developments for the company's governance and future operations.
Info Edge (India) Limited announced the appointment of Mr. Himanshu Agarwal as Chief Financial Officer (Key Managerial Personnel) and Additional Director, to be designated as Whole-time Director and Chief Financial Officer. This appointment is effective from September 17, 2026, for a term of five years, concluding on September 16, 2031. The appointment is subject to shareholder and other necessary statutory approvals.
Mr. Agarwal brings over three decades of experience in finance leadership, corporate governance, mergers and acquisitions, and business transformation. He has held senior finance roles at various prominent companies including ICI India Limited, AstraZeneca Pharma India Limited, AkzoNobel India Limited, Huhtamaki Oyj, Bennett, Coleman and Co. Limited, and currently serves as Whole Time Director and Chief Financial Officer of Cohance Lifesciences Limited. He is a qualified Chartered Accountant, Company Secretary, and Cost and Management Accountant.
The Board of Directors also approved the re-constitution of certain Committees of the Board of Directors, effective June 27, 2026. Ms. Radha Rajappa has been inducted as a Member of the Audit Committee. Mr. Rajesh Magow has been inducted as a Member of the Nomination & Remuneration Committee, and will assume the position of Chairman of this committee from July 21, 2026. These changes are to ensure a smooth transition and continuity, particularly in light of Mr. Ashish Gupta's term as an Independent Director ending on July 20, 2026.
The Board Meeting commenced at 07:34 p.m. and concluded at 07:55 p.m. on June 26, 2026. The company will intimate the stock exchanges upon Mr. Agarwal assuming office. Mr. Agarwal is not related to any Directors of the Company and is not disqualified from holding the office of Director.
What to do with a filing like this
Info Edge (India) Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Info Edge (India) Limited. Read the original for the full detail.